Co-Diagnostics, Inc. Research and Development Expense
Co-Diagnostics, Inc. (CODX) reported Research and Development Expense of $4.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- Co-Diagnostics, Inc. research and development expense for the quarter ending 2026-06-30 was $4.15M, a 11.42% decline year-over-year.
- Co-Diagnostics, Inc. research and development expense for the quarter ending 2026-03-31 was $5.93M, a 21.85% increase year-over-year.
- Co-Diagnostics, Inc. research and development expense for the quarter ending 2025-12-31 was $5.10M, a 6.08% increase year-over-year.
- Co-Diagnostics, Inc. research and development expense for the quarter ending 2025-09-30 was $4.48M, a 8.19% decline year-over-year.
- Co-Diagnostics, Inc. research and development expense for fiscal 2025 was $19.14M, a 8.78% decline from fiscal 2024.
- Co-Diagnostics, Inc. research and development expense for fiscal 2024 was $20.98M, a 8.64% decline from fiscal 2023.
- Co-Diagnostics, Inc. research and development expense for fiscal 2023 was $22.96M, a 31.68% increase from fiscal 2022.
- Co-Diagnostics, Inc. research and development expense for fiscal 2022 was $17.44M, a 16.55% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.15M 10-Q · filed 2026-08-13 | $10.09M 10-Q · filed 2026-08-13 | $15.19M derived: sum of 3 quarters · filed 2026-08-13 | $19.67M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $5.93M 10-Q · filed 2026-05-14 | $11.03M derived: sum of 2 quarters · filed 2026-05-14 | $15.51M derived: sum of 3 quarters · filed 2026-05-14 | $20.20M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.58M derived: sum of 2 quarters · filed 2026-03-31 | $14.27M derived: sum of 3 quarters · filed 2026-08-13 | $19.14M 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.48M 10-Q · filed 2025-11-13 | $9.17M derived: sum of 2 quarters · filed 2026-08-13 | $14.04M 10-Q · filed 2025-11-13 | $18.85M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $4.69M 10-Q · filed 2026-08-13 | $9.56M 10-Q · filed 2026-08-13 | $14.36M derived: sum of 3 quarters · filed 2026-08-13 | $19.24M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $4.87M 10-Q · filed 2026-05-14 | $9.68M derived: sum of 2 quarters · filed 2026-05-14 | $14.56M derived: sum of 3 quarters · filed 2026-05-14 | $20.17M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $9.69M derived: sum of 2 quarters · filed 2026-03-31 | $15.30M derived: sum of 3 quarters · filed 2026-03-31 | $20.98M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.88M 10-Q · filed 2025-11-13 | $10.49M derived: sum of 2 quarters · filed 2025-11-13 | $16.17M 10-Q · filed 2025-11-13 | $22.35M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $5.61M 10-Q · filed 2025-08-14 | $11.29M 10-Q · filed 2025-08-14 | $17.47M derived: sum of 3 quarters · filed 2025-08-14 | $23.26M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $5.68M 10-Q · filed 2025-05-08 | $11.86M derived: sum of 2 quarters · filed 2025-05-08 | $17.65M derived: sum of 3 quarters · filed 2025-05-08 | $23.63M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $11.97M derived: sum of 2 quarters · filed 2025-03-27 | $17.95M derived: sum of 3 quarters · filed 2025-03-27 | $22.96M 10-K · filed 2025-03-27 |
| 2023-09-30 | $5.79M 10-Q · filed 2024-11-07 | $11.77M derived: sum of 2 quarters · filed 2024-11-07 | $16.78M 10-Q · filed 2024-11-07 | $21.52M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $5.98M 10-Q · filed 2024-08-08 | $11.00M 10-Q · filed 2024-08-08 | $15.73M derived: sum of 3 quarters · filed 2024-08-08 | $20.77M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $5.01M 10-Q · filed 2024-05-09 | $9.75M derived: sum of 2 quarters · filed 2024-05-09 | $14.79M derived: sum of 3 quarters · filed 2024-05-09 | $18.68M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $9.78M derived: sum of 2 quarters · filed 2024-03-14 | $13.67M derived: sum of 3 quarters · filed 2024-03-14 | $17.44M 10-K · filed 2024-03-14 |
| 2022-09-30 | $5.04M 10-Q · filed 2023-11-09 | $8.93M derived: sum of 2 quarters · filed 2023-11-09 | $12.70M 10-Q · filed 2023-11-09 | $14.88M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $3.89M 10-Q · filed 2023-08-10 | $7.66M 10-Q · filed 2023-08-10 | $9.84M derived: sum of 3 quarters · filed 2023-08-10 | $15.74M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $3.77M 10-Q · filed 2023-05-11 | $5.95M derived: sum of 2 quarters · filed 2023-05-11 | $11.85M derived: sum of 3 quarters · filed 2023-05-11 | $16.52M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $8.08M derived: sum of 2 quarters · filed 2023-03-16 | $12.74M derived: sum of 3 quarters · filed 2023-03-16 | $14.96M 10-K · filed 2023-03-16 |
| 2021-09-30 | $5.89M 10-Q · filed 2022-11-10 | $10.56M derived: sum of 2 quarters · filed 2022-11-10 | $12.78M 10-Q · filed 2022-11-10 | $13.89M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $4.67M 10-Q · filed 2022-08-11 | $6.89M 10-Q · filed 2022-08-11 | $8.00M derived: sum of 3 quarters · filed 2022-08-11 | $8.92M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $2.22M 10-Q · filed 2022-05-12 | $3.33M derived: sum of 2 quarters · filed 2022-05-12 | $4.25M derived: sum of 3 quarters · filed 2022-05-12 | $5.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.04M derived: sum of 2 quarters · filed 2022-03-24 | $2.79M derived: sum of 3 quarters · filed 2022-03-24 | $3.19M 10-K · filed 2022-03-24 |
| 2020-09-30 | $921.89K 10-Q · filed 2021-11-12 | $1.67M derived: sum of 2 quarters · filed 2021-11-12 | $2.07M 10-Q · filed 2021-11-12 | $2.45M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $750.25K 10-Q · filed 2021-08-12 | $1.15M 10-Q · filed 2021-08-12 | $1.53M derived: sum of 3 quarters · filed 2021-08-12 | $1.86M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $400.02K 10-Q · filed 2021-05-13 | $780.53K derived: sum of 2 quarters · filed 2021-05-13 | $1.11M derived: sum of 3 quarters · filed 2021-05-13 | $1.42M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $380.51K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $711.54K derived: sum of 2 quarters · filed 2021-03-25 | $1.02M derived: sum of 3 quarters · filed 2021-03-25 | $1.37M 10-K · filed 2021-03-25 |
| 2019-09-30 | $331.03K 10-Q · filed 2020-11-16 | $643.62K derived: sum of 2 quarters · filed 2020-11-16 | $990.92K 10-Q · filed 2020-11-16 | $1.37M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $312.59K 10-Q/A · filed 2020-11-03 | $659.90K 10-Q/A · filed 2020-11-03 | $1.04M derived: sum of 3 quarters · filed 2020-11-03 | $1.37M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-03-31 | $347.31K 10-Q · filed 2020-05-14 | $722.73K derived: sum of 2 quarters · filed 2020-05-14 | $1.05M derived: sum of 3 quarters · filed 2020-05-14 | $1.41M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $375.43K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $705.85K derived: sum of 2 quarters · filed 2020-03-30 | $1.06M derived: sum of 3 quarters · filed 2020-03-30 | $1.36M 10-K · filed 2020-03-30 |
| 2018-09-30 | $330.42K 10-Q · filed 2019-11-12 | $688.31K derived: sum of 2 quarters · filed 2019-11-12 | $985.73K 10-Q · filed 2019-11-12 | $1.27M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $357.89K 10-Q · filed 2019-08-14 | $655.30K 10-Q · filed 2019-08-14 | $936.69K derived: sum of 3 quarters · filed 2019-08-14 | $1.21M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $297.42K 10-Q · filed 2019-05-14 | $578.80K derived: sum of 2 quarters · filed 2019-05-14 | $851.01K derived: sum of 3 quarters · filed 2019-05-14 | $1.04M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | $281.39K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $553.60K derived: sum of 2 quarters · filed 2019-04-01 | $738.48K derived: sum of 3 quarters · filed 2019-04-01 | $1.00M 10-K · filed 2019-04-01 |
| 2017-09-30 | $272.21K 10-Q · filed 2018-11-14 | $457.09K derived: sum of 2 quarters · filed 2018-11-14 | $721.78K 10-Q · filed 2018-11-14 | $914.43K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $184.88K 10-Q · filed 2018-08-10 | $449.57K 10-Q · filed 2018-08-10 | $642.22K derived: sum of 3 quarters · filed 2018-08-10 | $815.03K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $265.69K 10-Q · filed 2018-05-14 | $457.34K derived: sum of 2 quarters · filed 2018-05-14 | $630.15K derived: sum of 3 quarters · filed 2018-05-14 | $802.26K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $191.66K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $364.46K derived: sum of 2 quarters · filed 2018-03-28 | $536.57K derived: sum of 3 quarters · filed 2018-03-28 | $731.47K 10-K · filed 2018-03-28 |
| 2016-09-30 | $172.80K 10-Q · filed 2017-11-14 | $344.91K derived: sum of 2 quarters · filed 2017-11-14 | $539.82K 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $172.11K 10-Q · filed 2017-08-25 | $367.01K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |